RVTY Stifel maintains hold rating

PARAGRAPH 1 --- Revvity, Inc. (RVTY) reported strong Q1 2026 results, posting 3% organic growth, a 23.6% adjusted operating margin, and $115 million in free cash flow. The company repurchased $86 million of stock and ended the quarter with net debt/EBITDA of 2.8x. Stifel maintained a 'Hold' rating on RVTY with a $110 price target, following a meeting with management who expressed cautious optimism.

PARAGRAPH 2 --- The healthcare sector, particularly companies focused on health sciences solutions and diagnostic services, is affected. Revvity's robust earnings and free cash flow generation drive investor confidence. However, Stifel's 'Hold' rating tempers enthusiasm, suggesting potential headwinds or uncertainty.

PARAGRAPH 3 --- Next, watch for Revvity's Q2 earnings report, scheduled for late July 2026. Additionally, monitor Artisan Mid Cap Value Fund's portfolio activity, as their investment thesis for RVTY could influence the stock's performance. Lastly, keep an eye on Revvity's debt levels, as net debt/EBITDA of 2.8x may raise concerns if it continues to rise.